top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
New Therapies of Liver Diseases
New Therapies of Liver Diseases
Autore Toniutto Pierluigi
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (236 p.)
Soggetto topico Public health & preventive medicine
Soggetto non controllato tolvaptan
cirrhotic ascites
survival rate
furosemide
primary biliary cholangitis
autoantibodies
ursodeoxycholic acid
treatment response
second line therapy
primary biliary cholangitis (PBC)
primary sclerosing cholangitis (PSC)
clinical trials
ursodeoxycholic acid (UDCA)
Farnesoid X Receptor (FXR) agonist
Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists
liver cancer
systemic treatment
immunotherapy
real-world
unresectable hepatocellular carcinoma
cirrhosis
decompensation
bleeding
varices
survival
infection
alcoholic hepatitis
acute-on-chronic liver failure
cholangiocarcinoma
colorectal cancer metastases
hepatocellular carcinoma
liver transplantation
Milan criteria
alpha-fetoprotein
solid organ transplantation
liver injury
immunosuppressant
SARS-CoV-2
humoral response
vaccination
portal-systemic shunt
ammonia
vigilance
HBV
HDV
antivirals
functional cure
pharmacology
acute-on-chronic liver failure (ACLF)
liver transplantation (LT)
decompensated cirrhosis
portal hypertension
ascites
non-selective beta-blockers
TIPS
rifaximin
human albumin
statins
targeted therapy
effective hypovolemia
anti-mineralocorticoids
loop diuretics
vaptans
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566457403321
Toniutto Pierluigi  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting the Microbiome for Disease Diagnosis and Therapy : New Frontiers for Personalized Medicine
Targeting the Microbiome for Disease Diagnosis and Therapy : New Frontiers for Personalized Medicine
Autore Laterza Lucrezia
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (280 p.)
Soggetto topico Medicine
Soggetto non controllato Graves-Basedow's diseases
Hashimoto's thyroiditis
autoimmunity
gut microbiota
irritable bowel syndrome
microbiota
microbiome
food components
nutrients
hematopoietic stem cell transplantation
fecal microbiota transplantation
aGvHD
antibiotic-resistant bacteria
cystic fibrosis
rabbits
intestinal dysbiosis
feces microbiome
beta-blocker
hemodialysis
next-generation sequencing
propensity score matching methods
violin plots
random sampling
analytical reproducibility
fecal matter transplantation
data disease subtypes
personalized medicine
maltodextrin
dip test
gallstone disease
16S rDNA gene diversity
blood biochemical characteristics
mesothelioma
16S RNA sequencing
species
probiotics and gut disease
probiotics and acute diverticulitis
probiotics and diverticular disease
probiotics mechanism of action
IgA Nephropathy
rifaximin
α1KI-CD89Tg mice
children
intermittent hypoxemia
obstructive sleep apnea
tonsil
weight status
oral microbiota
rheumatology diseases
biomarkers
artificial intelligence
machine learning
rheumatoid arthritis
Sjogren's syndrome
systemic lupus erythematosus
endometrial cancer
endometrial microbiome
gut microbiome
dysbiosis
estrogen metabolism
estrobolome
inflammation
antitumour treatment
prebiotics
probiotics
schizophrenia
depression
anxiety
functional genes
thymoma
genera
driver mutation
cardiovascular diseases
critically ill
intestinal permeability
recurrent cystitis
ISBN 3-0365-5611-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Targeting the Microbiome for Disease Diagnosis and Therapy
Record Nr. UNINA-9910637781403321
Laterza Lucrezia  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui